Moreover, we observed that 2-week URB597 treatment caused a substantial reduction in cardiac DAG pool in the model of primary hypertension compared to the hypertensive group not treated with FAAH inhibitor (–21.8%, P < 0.05; Figure 2a). Here, FAAH is linked to essential hypertension.